United Therapeutics UTHR Other Noncash Income (Expense)
Other Noncash Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by United Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.
The official record: United Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about United Therapeutics's other noncash income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is United Therapeutics's other noncash income (expense)?
- United Therapeutics (UTHR) reported other noncash income (expense) of -$32M in Q1 2026.
- How has United Therapeutics's other noncash income (expense) changed year-over-year?
- United Therapeutics's other noncash income (expense) decreased by 680.5% year-over-year, from -$4.1M to -$32M.
- What is the long-term trend for United Therapeutics's other noncash income (expense)?
- Over 3 years (2021 to 2025), United Therapeutics's other noncash income (expense) has grown at a -33.1% compound annual growth rate (CAGR), from -$65.9M to $19.7M.
- What does other noncash income (expense) mean?
- This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.